Cost Effectiveness of Colorectal Cancer Screening Strategies in Middle‐ and High‐Income Countries: A Systematic Review
Journal of Gastroenterology and Hepatology · 2025
DOI: 10.1111/jgh.16882 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Journal of Gastroenterology and Hepatology, 2025. Verfasst von Yuxuan Li und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epidemiology and Biostatistics, School of Public Health, Xi'an Jiaotong University, Xi'an, Shaanxi, China. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Cost-Effectiveness Analysis, Developed Countries, Early Detection of Cancer. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 47 Literaturangaben.
Abstract (Originalsprache)
Background and Aim Colorectal cancer (CRC) is a significant global health burden, and screening can greatly reduce CRC incidence and mortality. Previous studies investigated the economic effects of CRC screening. We performed a systematic review to provide the cost‐effectiveness of CRC screening strategies across countries with different income levels.
Methods
We searched relevant scientific databases (PubMed, Embase, Ovid, Web of Science, Scopus) from January 1, 2010, to December 31, 2023. We selected English‐language studies related to model‐based economic evaluations of CRC screening strategies. Information such as the characters of screening tests, model characteristics, and key cost‐effectiveness findings were collected. The net monetary benefit approach was used to compare the outcomes of various strategies.
Results
A total of 56 studies were identified, including 46 from high‐income countries (HICs), 6 from upper‐middle‐income countries (UMICs), and 4 from lower‐middle‐income countries (LMICs). Most annual fecal occult blood tests and fecal immunochemical tests were cost‐saving, and colonoscopy every 10 years was cost‐saving. Other strategies involving multitarget fecal FIT‐DNA detection, computed tomography colonography, and flexible sigmoidoscopy were cost‐effective compared with no screening. Newer strategies such as magnetic resonance colonography every 5 years, annual urine metabolomic tests, and fecal bacterial biomarkers were cost‐effective compared with no screening.
Conclusion
In our updated review, we found that common CRC screening strategies and magnetic resonance colonography continued to be cost‐effective compared with no screening. Areas for further development include accurately modeling the natural history of colorectal cancer and obtaining more evidence from UMICs and LMICs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Epidemiology and Biostatistics, School of Public Health, Xi'an Jiaotong University, Xi'an, Shaanxi, China.
ORCID-Profile: Yuxuan Li
Zitieren
APA
Li, Y., Xia, R., Si, W., Zhang, W., Zhang, Y., & Zhuang, G. (2025). Cost Effectiveness of Colorectal Cancer Screening Strategies in Middle‐ and High‐Income Countries: A Systematic Review. Journal of Gastroenterology and Hepatology. https://doi.org/10.1111/jgh.16882
Vancouver
Li Y, Xia R, Si W, Zhang W, Zhang Y, Zhuang G. Cost Effectiveness of Colorectal Cancer Screening Strategies in Middle‐ and High‐Income Countries: A Systematic Review. Journal of Gastroenterology and Hepatology. 2025. doi:10.1111/jgh.16882
BibTeX
@article{Li2025,
author = {Li, Yuxuan and Xia, Ruyi and Si, Wenwen and Zhang, Wendi and Zhang, Yunbo and Zhuang, Guihua},
title = {Cost Effectiveness of Colorectal Cancer Screening Strategies in Middle‐ and High‐Income Countries: A Systematic Review},
journal = {Journal of Gastroenterology and Hepatology},
year = {2025},
doi = {10.1111/jgh.16882}
}
EUVIMED